- Home
- SMSI vs GLYC Comparison
SMSI vs GLYC Comparison
Compare SMSI & GLYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- GLYC
- Stock Information
- Founded
- SMSI 1982
- GLYC 2003
- Country
- SMSI United States
- GLYC United States
- Employees
- SMSI N/A
- GLYC N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- GLYC Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- GLYC Health Care
- Exchange
- SMSI Nasdaq
- GLYC Nasdaq
- Market Cap
- SMSI 16.2M
- GLYC 17.0M
- IPO Year
- SMSI 1995
- GLYC 2014
- Fundamental
- Price
- SMSI $1.13
- GLYC $0.26
- Analyst Decision
- SMSI Strong Buy
- GLYC Hold
- Analyst Count
- SMSI 1
- GLYC 2
- Target Price
- SMSI $5.00
- GLYC N/A
- AVG Volume (30 Days)
- SMSI 732.1K
- GLYC 531.4K
- Earning Date
- SMSI 02-20-2025
- GLYC 11-13-2024
- Dividend Yield
- SMSI N/A
- GLYC N/A
- EPS Growth
- SMSI N/A
- GLYC N/A
- EPS
- SMSI N/A
- GLYC N/A
- Revenue
- SMSI $24,178,000.00
- GLYC $10,000.00
- Revenue This Year
- SMSI N/A
- GLYC N/A
- Revenue Next Year
- SMSI $53.43
- GLYC N/A
- P/E Ratio
- SMSI N/A
- GLYC N/A
- Revenue Growth
- SMSI N/A
- GLYC N/A
- 52 Week Low
- SMSI $0.52
- GLYC $0.14
- 52 Week High
- SMSI $7.52
- GLYC $3.53
- Technical
- Relative Strength Index (RSI)
- SMSI 47.52
- GLYC 48.18
- Support Level
- SMSI $1.05
- GLYC $0.19
- Resistance Level
- SMSI $1.95
- GLYC $0.27
- Average True Range (ATR)
- SMSI 0.23
- GLYC 0.03
- MACD
- SMSI -0.06
- GLYC 0.00
- Stochastic Oscillator
- SMSI 8.89
- GLYC 42.86
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. It offers multi-platform, modular solutions such as SafePath; CommSuite; and ViewSpot. The company's only reportable segment is Wireless. Its Wireless segment sells to large wireless carriers, cable operators, and OEMs.
About GLYC GlycoMimetics Inc.
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.